Fukumoto Shinya, Sakaguchi Takeshi, You Myungio, Xuan Xuenan, Fujisaki Kozo
Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
Microvasc Res. 2006 May;71(3):218-21. doi: 10.1016/j.mvr.2006.02.003. Epub 2006 Apr 24.
This is the first report identifying the anti-angiogenesis saliva molecule of the ixodid tick. In our previous study, we identified a troponin I-like molecule (HLTnI) of the ixodid hard tick Haemaphysalis longicornis, a vector for various pathogens. To investigate its potential inhibitory effects for angiogenesis, we expressed and purified recombinant HLTnI in Escherichia coli. In a vascular endothelial growth factor (VEGF) competitive angiogenesis assay, the recombinant HLTnI significantly inhibited the capillary formation of human vascular endothelial cells (HUVEC) in vitro. The inhibition was dose-dependent with an IC(50) of 18.95 nM. These results indicated that HLTnI is a potent angiogenesis inhibitor.
这是首篇鉴定出硬蜱抗血管生成唾液分子的报告。在我们之前的研究中,我们鉴定出了长角血蜱(一种多种病原体的传播媒介)的肌钙蛋白I样分子(HLTnI)。为了研究其对血管生成的潜在抑制作用,我们在大肠杆菌中表达并纯化了重组HLTnI。在血管内皮生长因子(VEGF)竞争性血管生成试验中,重组HLTnI在体外显著抑制了人血管内皮细胞(HUVEC)的毛细血管形成。这种抑制呈剂量依赖性,IC50为18.95 nM。这些结果表明HLTnI是一种有效的血管生成抑制剂。